The role of elotuzumab-based combinations in multiple myeloma therapy

Описание к видео The role of elotuzumab-based combinations in multiple myeloma therapy

Michael Slade, MD, Washington University School of Medicine, St Louis, MO, talks on the role of elotuzumab-based therapies in multiple myeloma, explaining that its place in the treatment algorithm of multiple myeloma remains unclear. Nevertheless, anecdotal evidence suggests that elotuzumab-based triplet combinations appear to be more beneficial in patients with slowly progressing disease. This interview took place at the 2023 Transplantation & Cellular Therapy Meetings of ASTCT™ and CIBMTR® held in Orlando, FL.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Комментарии

Информация по комментариям в разработке

Похожие видео